Oncology CRO Oncotherapeutics Presents at ASH 2011 Annual Meeting

Nov 23, 2011

Oncotherapeutics, an oncology specific Contract Research Organization (CRO) specializing in the oversight and management of clinical trails for cnacer, will present final results from a multicenter clinical trial at the American Society of Hematology Annual Meeting in San Diego, CA on December 10-13, 2011.

All Press

Make an Appointment

Contact Dr. Berenson's Office

Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

Feb 8, 2022

On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest...

IMBCR & Emory University’s Big Discovery!!!

Feb 7, 2022

Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against...

James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center

Feb 6, 2022

New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative LOS ANGELES, Nov....

Oncology CRO Oncotherapeutics Presents at ASH 2011 Annual Meeting

Make an Appointment

Related Articles

Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

IMBCR & Emory University’s Big Discovery!!!

James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center

Myeloma-Related Conditions

James R. Berenson, MD

Quick Links

Call Us for an Appointment